$OM News

Outset Medical, Inc. (OM) Q1 2026 Earnings Call Transcript

Outset Medical (NASDAQ:OM) Falls After Q1 Revenue Miss, Despite Record Gross Margins

Outset Medical Affirms FY2026 Sales Guidance of $125.000M-$130.000M vs $126.767M Est

Outset Medical Q1 Adj. EPS $(0.83) Misses $(0.79) Estimate, Sales $27.863M Miss $28.900M Estimate

Outset Medical shares are trading lower after BTIG lowered its price target on the stock from $17 to $15.

Outset Medical shares are trading lower after BTIG lowered its price target on the stock from $17 to $15.

BTIG Maintains Buy on Outset Medical, Lowers Price Target to $15

Outset Medical Inc (NASDAQ:OM) Reports Q4 Revenue Beat but Wider Loss, Shares Fall

Outset Medical, Inc. (OM) Q4 2025 Earnings Call Transcript

Outset Medical Q4 Earnings Report: What Investors Need to Know

Outset Medical Sees FY2026 Sales $125.000M-$130.000M vs $127.650M Est

Outset Medical Q4 Adj. EPS $(0.84) Misses $(0.64) Estimate, Sales $28.874M Beat $26.650M Estimate

Outset Medical shares are trading higher after the company announced that it has received the FDA clearance for its next-gen Tablo platform.

Outset Medical Gets FDA's Clearance For Its Tablo Platform

Outset Medical, Inc. (OM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Outset Medical Sees Q4 2025 Revenue ~$28.9M Vs $26.15M Estimate

Stifel Maintains Buy on Outset Medical, Lowers Price Target to $8

BTIG Reiterates Buy on Outset Medical, Maintains $17 Price Target

Outset Medical (OM): Assessing Valuation After Q3 Miss, Sales Leadership Exit, and Steep Stock Drop

SoftBank Sale of Nvidia Stake Weighs on Tech Sector, Driving Mixed Premarket Action for US Equity Futures